Innovative Pickering emulsions with encapsulated creatine offer improved stability and controlled release profiles. Ideal for nutraceutical applications, this technology enhances the bioavailability of creatine. Currently at TRL 4, seeking co-development partnerships for further validation.
Thammasat University presents an innovative approach to enhancing creatine stability and controlled release through encapsulation in Pickering emulsions. This technology leverages the unique properties of Pickering emulsions to improve the bioavailability and stability of creatine, a popular supplement used for its muscle-enhancing benefits. The encapsulation in these emulsions ensures better protection and a controlled release profile, making it highly suitable for nutraceutical applications.
Key features:
Applications:
This technology is currently at TRL 4, indicating that it has been validated in a laboratory setting. Further development and co-validation are sought to bring this technology to market readiness.
Thammasat University is a large comprehensive public research university in Thailand, with nearly 40,000 students and more than 9,000 staff across campuses in Bangkok, Pathum Thani, Chonburi, and Lampang. Its multi-campus model gives corporate R&D teams access to advanced laboratories, shared research infrastructure, engineering talent, and university–industry collaboration. The Rangsit campus is integrated with Thammasat University Hospital, supporting clinical research, training, and translation, while cooperative education connects employers with students and graduates. Research is supported by competitive national funding and external partnerships, including Thailand’s major research and innovation agencies. Intellectual-property and business-incubation services support technology transfer and commercialization.